儿童原发性打鼾与轻度阻塞性睡眠呼吸暂停的临床特征:儿童打鼾腺样体扁桃体切除术(PATS)随机临床试验分析
本研究分析PATS随机临床试验的基线数据,纳入459例3.0至12.9岁、多导睡眠图诊断AHI<3的轻度阻塞性睡眠呼吸障碍儿童,比较原发性打鼾(AHI<1,311例[67.8%])与轻度OSA(AHI 1-3,148例[32.2%])的临床特征。黑种人种族、肥胖和高尿可替宁水平与轻度OSA而非原发性打鼾的较高几率相关,但其他人口学、临床检查和问卷报告无法区分两者。结论认为不依赖多导睡眠图难以区分原发性打鼾与轻度OSA,轻度OSA与单纯打鼾的区分未能识别可能从腺样体扁桃体切除术中获益的儿童临床组。
要点
- 黑种人种族、肥胖和高尿可替宁水平与轻度OSA而非原发性打鼾的较高几率相关。
- 其他人口学特征、临床检查发现和问卷报告不能区分原发性打鼾与轻度OSA。
- 不依赖多导睡眠图难以区分原发性打鼾与轻度OSA。
核心结论
- 在本PATS随机临床试验基线数据分析中,不依赖多导睡眠图难以区分原发性打鼾与轻度OSA。
- 轻度OSA与单纯打鼾的区分未能识别可能从腺样体扁桃体切除术中获益的儿童临床组。
研究设计与样本
- PATS研究为多中心、单盲、随机临床试验,在6个学术睡眠中心于2016年6月至2021年1月开展。
- 分析纳入459例3.0至12.9岁、多导睡眠图诊断(AHI<3)的轻度阻塞性睡眠呼吸障碍且被认为是腺样体扁桃体切除术候选者的儿童。
- 数据分析于2022年7月至2023年10月进行。
- 拟合逻辑回归模型识别区分原发性打鼾(AHI<1;311例[67.8%])与轻度OSA(AHI 1-3;148例[32.2%])的人口学、临床和照护者报告特征。
主要发现
- 459例儿童中,中位(IQR)年龄为6.0(4.0-7.5)岁,230例(50.1%)为女性,88例(19.2%)有肥胖。
- 121例(26.4%)为黑种人,75例(16.4%)为西班牙裔,236例(51.5%)为白种人,26例(5.7%)为其他种族和族裔。
- 黑种人种族(OR 2.08;95%CI 1.32-3.30)、肥胖(OR 1.80;95%CI 1.12-2.91)和高尿可替宁水平(>5 µg/L)(OR 1.88;95%CI 1.15-3.06)与轻度OSA而非原发性打鼾的较高几率相关。
- 其他人口学特征、临床检查发现和问卷报告不能区分原发性打鼾与轻度OSA。
- 统计学显著临床预测因素的加权组合区分轻度OSA与原发性打鼾的能力有限。
关键数值与推荐
- 原发性打鼾定义为AHI<1(311例[67.8%]),轻度OSA定义为AHI 1-3(148例[32.2%])。
- 高尿可替宁水平定义为>5 µg/L(OR 1.88;95%CI 1.15-3.06)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: It is unknown whether children with primary snoring and children with mild obstructive sleep apnea (OSA) represent populations with substantially different clinical characteristics. Nonetheless, an obstructive apnea-hypopnea index (AHI) of 1 or greater is often used to define OSA and plan for adenotonsillectomy (AT). OBJECTIVE: To assess whether a combination of clinical characteristics differentiates children with primary snoring from children with mild OSA. DESIGN, SETTING, AND PARTICIPANTS: Baseline data from the Pediatric Adenotonsillectomy Trial for Snoring (PATS) study, a multicenter, single-blind, randomized clinical trial conducted at 6 academic sleep centers from June 2016 to January 2021, were analyzed. Children aged 3.0 to 12.9 years with polysomnography-diagnosed (AHI <3) mild obstructive sleep-disordered breathing who were considered candidates for AT were included. Data analysis was performed from July 2022 to October 2023. MAIN OUTCOMES AND MEASURES: Logistic regression models were fitted to identify which demographic, clinical, and caregiver reports distinguished children with primary snoring (AHI <1; 311 patients [67.8%]) from children with mild OSA (AHI 1-3; 148 patients [32.2%]). RESULTS: A total of 459 children were included. The median (IQR) age was 6.0 (4.0-7.5) years, 230 (50.1%) were female, and 88 (19.2%) had obesity. A total of 121 (26.4%) were Black, 75 (16.4%) were Hispanic, 236 (51.5%) were White, and 26 (5.7%) were other race and ethnicity. Black race (odds ratio [OR], 2.08; 95% CI, 1.32-3.30), obesity (OR, 1.80; 95% CI, 1.12-2.91), and high urinary cotinine levels (>5 µg/L) (OR, 1.88; 95% CI, 1.15-3.06) were associated with greater odds of mild OSA rather than primary snoring. Other demographic characteristics, clinical examination findings, and questionnaire reports did not distinguish between primary snoring and mild OSA. A weighted combination of the statistically significant clinical predictors had limited ability to differentiate children with mild OSA from children with primary snoring. CONCLUSIONS AND RELEVANCE: In this analysis of baseline data from the PATS randomized clinical trial, primary snoring and mild OSA were difficult to distinguish without polysomnography. Mild OSA vs snoring alone did not identify a clinical group of children who may stand to benefit from AT for obstructive sleep-disordered breathing. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02562040.
引用
- Mitchell RB, Cook K, Garetz S, et al. Clinical Characteristics of Primary Snoring vs Mild Obstructive Sleep Apnea in Children: Analysis of the Pediatric Adenotonsillectomy for Snoring (PATS) Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2024. PMID: 38095903. doi:10.1001/jamaoto.2023.3816
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。